Journal of Clinical Medicine (Jan 2022)

ONLINE-TICS: Internet-Delivered Behavioral Treatment for Patients with Chronic Tic Disorders

  • Martina Haas,
  • Ewgeni Jakubovski,
  • Katja Kunert,
  • Carolin Fremer,
  • Nadine Buddensiek,
  • Sebastian Häckl,
  • Martina Lenz-Ziegenbein,
  • Richard Musil,
  • Veit Roessner,
  • Alexander Münchau,
  • Irene Neuner,
  • Armin Koch,
  • Kirsten Müller-Vahl

DOI
https://doi.org/10.3390/jcm11010250
Journal volume & issue
Vol. 11, no. 1
p. 250

Abstract

Read online

Comprehensive Behavioral Intervention for Tics (CBIT) is considered a first-line therapy for tics. However, availability of CBIT is extremely limited due to a lack of qualified therapists. This study is a multicenter (n = 5), randomized, controlled, observer-blind trial including 161 adult patients with chronic tic disorders (CTD) to provide data on efficacy and safety of an internet-delivered, completely therapist-independent CBIT intervention (iCBIT Minddistrict®) in the treatment of tics compared to placebo and face-to-face (f2f) CBIT. Using a linear mixed model with the change to baseline of Yale Global Tic Severity Scale-Total Tic Score (YGTSS-TTS) as a dependent variable, we found a clear trend towards significance for superiority of iCBIT (n = 67) over placebo (n = 70) (−1.28 (−2.58; 0.01); p = 0.053). In addition, the difference in tic reduction between iCBIT and placebo increased, resulting in a significant difference 3 (−2.25 (−3.75; −0.75), p = 0.003) and 6 months (−2.71 (−4.27; −1.16), p n = 24). No safety signals were detected. Although the primary endpoint was narrowly missed, it is strongly suggested that iCBIT is superior compared to placebo. Remarkably, treatment effects of iCBIT even increased over time.

Keywords